Process for preparing p-hydroxycinnamic acid
Patent Information
- Application Number
- EP2023701713
- Authority / Receiving Office
- EP · EP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-01-25
- Filing Date
- 2023-01-24
- Publication Date
- 2024-12-04
AI Technical Summary
Current methods for producing para-hydroxycinnamic acid, such as the Knoevenagel reaction, face challenges due to the use of toxic solvents like pyridine or toluene, which pose health and environmental risks, and are affected by side reactions like decarboxylation, necessitating large malonic acid quantities.
A process involving the reaction of para-hydroxybenzaldehyde with malonic acid in the presence of at least one amino acid and acetic acid, under controlled conditions, to efficiently and selectively produce para-hydroxycinnamic acid, utilizing a bio-based carbon source and minimizing solvent use and side reactions.
This process reduces environmental impact and health risks, improves reaction performance, and allows for the efficient industrial-scale production of para-hydroxycinnamic acid with high bio-based carbon content, achieving high yields and purity.
Smart Images

Figure IMGF000003_0001 
Figure IMGF000004_0001 
Figure IMGF000005_0001
Abstract
Description
[0001] DESCRIPTION
[0002] Process for the preparation of p-hydroxycinnamic acid
[0003] Field of invention
[0004] The present invention relates to a process for the preparation of para-hydroxycinnamic acid, in particular from para-hydroxybenzaldehydes.
[0005] Prior art
[0006] Para-hydroxycinnamic acids are used in a wide range of fields, including as synthetic intermediates. They can be used in the synthesis of active molecules, antioxidants, aromas, resins, and polymers.
[0007] One method to produce these para-hydroxycinnamic acids is to use a Knoevenagel reaction.
[0008] However, the use of this type of process is rarely used industrially because it requires the use of large quantities of a toxic solvent: pyridine or toluene, we can cite in particular US 7572809, P 2018123127, CN 103242163. The use of these solvents poses toxicological problems: these solvents can have effects on human health and the environment. Alternatives have been proposed with the use of aniline or piperidine, a little less dangerous, but reducing their use is still desirable.
[0009] The reaction performance is also affected by side reactions related to the decarboxylation of malonic acid or para-hydroxycinnamic acid. To overcome this decarboxylation problem, it is sometimes necessary to add malonic acid in large quantities, such as in CN 1027756 or in Peyrot et al. ACS Sustainable Chemistry & Engineering, 2019, 7 (10), pp.9422-9427.
[0010] In order to be able to industrially implement a process for preparing para-hydroxycinnamic acid from para-hydroxybenzaldehyde, it is therefore desirable to be able to propose a process whose environmental footprint and performance are improved. It is also desirable to propose an industrial process reducing risks to human health. The present invention aims at the efficient and selective manufacture of para-hydroxycinnamic acid, on an industrial scale, economically and under good safety conditions. Brief description
[0011] The present invention relates to a process for the preparation of para-hydroxycinnamic acid of formula (I) ormuk' (!) in which RI and R2 are, identical or different, independently, selected from the group consisting of hydrogen, optionally substituted linear or branched C1-C6 alkyl groups, optionally substituted linear or branched C1-C6 alkenyl groups, -CO2R, -OR, in which R is selected from hydrogen, optionally substituted linear or branched C1-C6 alkyl groups, optionally substituted linear or branched C1-C6 alkenyl groups, in which a para-hydroxybenzaldehyde of formula (II) in which RI and R2 are as described above
[0012]
[0013] Formula: It is reacted with malonic acid in the presence of at least one amino acid and acetic acid.
[0014] Detailed description
[0015] For the purposes of the present invention, and unless otherwise indicated, the expression "between ... and..." includes the limits. Unless otherwise indicated, the percentages and ppm are percentages and ppm by mass.
[0016] In the context of the present invention, the expression "bio-based carbon" or "bio-based carbon" refers to carbons of renewable origin such as agricultural, plant, animal, fungal, microorganism, marine or forest living in a natural environment in equilibrium with the atmosphere. The bio-based carbon content is typically evaluated by means of carbon-14 dating (also called carbon dating or radiocarbon dating). Furthermore, in the present invention, the "bio-based carbon content" refers to the molar ratio of bio-based carbon to the total carbon of the compound or product. The bio-based carbon content can preferably be measured by a method consisting of measuring the decay process of the 14C (carbon-14), in disintegrations per minute per gram of carbon (or 10 dpm / gC), by liquid scintillation counting, preferably according to ASTM D6866-16 Standard Test Method. Said American Standard Test AS TM D6866 would be equivalent to ISO 16620-2. According to said ASTM D6866, the test method may preferably use AMS (Accelerator Mass Spectrometry) techniques with IRMS 13 C (Isotope Ratio Mass Spectrometry) to quantify the bio-sourced content of a given product.
[0017] Carbon atoms naturally coexist with their stable isotopes 13 C. Quantity and ratio 13 C / 12 It is influenced by several factors such as the environment for natural products. The isotopic fingerprint of a product provides information on the origin of the product, particularly the natural or fossil origin. The method 13 C-SNIF-NMR measures the ratio 13 C / 12C of each site of a molecule.
[0018] Isotopic deviation 13 C average (ô 13 C) is measured by isotope ratio mass spectrometry (IRMS) against PDB (pee bee belemnite), the international reference standard.
[0019] The present invention relates to a process for the preparation of para-hydroxycinnamic acid of formula (I)
[0020] Forniuk' (!) in which RI and R2 are, identical or different, independently, selected from the group consisting of hydrogen, optionally substituted linear or branched C1-C6 alkyl groups, optionally substituted linear or branched C1-C6 alkenyl groups, -CO2R, -OR, in which R is selected from hydrogen, optionally substituted linear or branched C1-C6 alkyl groups, optionally substituted linear or branched C1-C6 alkenyl groups, in which a para-hydroxybenzaldehyde of formula (II) in which RI and R2 are as described above
[0021]
[0022] Formula: It is reacted with malonic acid in the presence of at least one amino acid and acetic acid.
[0023] p-Hydroxycinnamic acid: In the context of the present invention, a p-hydroxycinnamic acid refers to a compound of formula (I): r'oTsnuh' ( ! in which RI and R2 are, identical or different, independently, selected from the group consisting of hydrogen, optionally substituted linear or branched C1-C6 alkyl groups, optionally substituted linear or branched C1-C6 alkenyl groups, - CO2R, -OR, in which R is selected from hydrogen, optionally substituted linear or branched C1-C6 alkyl groups, optionally substituted linear or branched C1-C6 alkenyl groups. In the context of the present invention the carbon-carbon double bond may be trans or cis, preferably the carbon-carbon double bond is trans. The compound of formula (I) may be a compound of formula (Ia) or (Ib) in which RI, R2 and R are as described above.
[0024] Fornm'.e (Tn i Formai." ! Th)
[0025] In a particular aspect, R1 is hydrogen and R2 is a methoxy or ethoxy group. The compound of formula (I) may be ferulic acid or 3-(4-hydroxy-3-ethoxyphenyl)prop-2-enoic acid, preferably the compound of formula (I) is / raw.s-ferulic acid.
[0026] According to a particular aspect, the compound of formula (I) obtained within the framework of the present invention may be of fossil, biosourced, natural or renewable origin.
[0027] In the context of the present invention, the content of carbon of biosourced origin of the compound of formula (I) is greater than or equal to 50%, preferably greater than or equal to 70%, very preferably greater than or equal to 90%, for example 97%, 98%, 99%. In the context of the present invention, the content of carbon of biosourced origin of the compound of formula (I) is less than or equal to 105%, preferably less than or equal to 103%, very preferably less than or equal to 100%.
[0028] In the context of the present invention, at least 6 carbon atoms of the compound of formula (I) are of biosourced origin, preferably at least 7 carbon atoms are of biosourced origin, preferably all the carbon atoms of the compound of formula (I) are of biosourced origin. According to a particular aspect, the compound of formula (I) may have an average isotopic deviation 13 C between -38%o and -28%o or between -25%o and -18%o. p-Hydroxybenzaldehyde:
[0029] For the purposes of the present invention, a p-hydroxycinnamic acid refers to a compound of formula (II):
[0030] Formula: II! in which R1 and R2 are, identical or different, independently, selected from the group consisting of hydrogen, optionally substituted linear or branched C1-C6 alkyl groups, optionally substituted linear or branched C1-C6 alkenyl groups, -CO2R, -OR, in which R is selected from hydrogen, optionally substituted linear or branched C1-C6 alkyl groups, optionally substituted linear or branched C1-C6 alkenyl groups.
[0031] In a particular aspect, R1 is hydrogen and R2 is hydrogen or a methoxy or ethoxy group.
[0032] The compound of formula (II) may be para-hydroxybenzaldehyde, vanillin or ethylvanillin.
[0033] According to a particular aspect, the compound of formula (II) used in the context of the present invention may be of fossil, biosourced, natural or renewable origin.
[0034] In the context of the present invention, the content of carbon of biosourced origin of the compound of formula (II) is greater than or equal to 50%, preferably greater than or equal to 70%, very preferably greater than or equal to 90%, for example 97%, 98%, 99%. In the context of the present invention, the content of carbon of biosourced origin of the compound of formula (II) is less than or equal to 105%, preferably less than or equal to 103%, very preferably less than or equal to 100%.
[0035] In the context of the present invention, at least 6 carbon atoms of the compound of formula
[0036] (II) are of biosourced origin, preferably at least 7 carbon atoms are of biosourced origin, preferably all the carbon atoms of the compound of formula (II) are of biosourced origin.
[0037] In a particular aspect, the compound of formula (II) is vanillin which is not of fossil origin.
[0038] According to a particular aspect, the compound of formula (II) is vanillin of biosourced origin, preferably the vanillin may have an average isotopic deviation 13 C between -38%o and -28%o or between -25%o and -18%o.
[0039] Malonic acid:
[0040] For the purposes of the present invention, malonic acid refers to a compound of formula
[0041] (III):
[0042] Formula ( HJ 'I
[0043] According to a particular aspect, the compound of formula (III) used in the context of the present invention may be of fossil, biosourced, natural or renewable origin.
[0044] According to a particular aspect, the compound of formula (III) is of fossil origin.
[0045] According to a particular aspect, the compound of formula (III) is not of fossil origin.
[0046] In the context of the present invention, the carbon content of biosourced origin of the compound of formula (III) is greater than or equal to 50%, preferably greater than or equal to 70%, very preferably greater than or equal to 90%, for example 97%, 98%, 99%. In the context of the present invention, the carbon content of biosourced origin of the compound of formula (III) is less than or equal to 105%, preferably less than or equal to 103%, very preferably less than or equal to 100%. In the context of the present invention, at least 1 carbon atom of the compound of formula (III) is of biosourced origin, preferably at least 2 carbon atoms are of biosourced origin, preferably all the carbon atoms of the compound of formula (III) are of biosourced origin. According to a particular aspect, the compound of formula (III) is of biosourced origin, preferably can have a 13C isotopic deviation of between -22%o and -17%o.
[0047] Amino acid:
[0048] In the context of the present invention, and unless otherwise indicated, the term "amino acid" refers to a compound having both a carboxylic acid function and an amine group, primary or secondary. In the context of the present invention, the term "amino acid" preferably refers to proline, glycine, histidine.
[0049] Process:
[0050] The present invention relates to a process in which a compound of formula (II) is reacted with malonic acid to form a compound of formula (I).
[0051] The process can be described according to the scheme below comprising a first condensation step between the compound of formula (II) and the malonic acid of formula (III), making it possible to form a diacid intermediate, followed by a decarboxylation step allowing the formation of the compound of formula (I):
[0052]
[0053] The process of the present invention can be operated continuously or in batch.
[0054] Generally, the process of the present invention is carried out under an inert atmosphere, for example under nitrogen, argon or under oxygen-depleted air. The process of the present invention is generally carried out with stirring.
[0055] The process of the present invention is generally carried out at a temperature at which the solvent or solvent mixture is refluxing, for example at a temperature between 50°C and 110°C.
[0056] The process of the present invention is generally operated under reduced pressure or atmospheric pressure.
[0057] The duration of the process is generally between 2 hours and 24 hours, preferably between 4 hours and 12 hours.
[0058] According to the invention, the process for preparing a compound of formula (I) is carried out in the presence of at least one amino acid and acetic acid. Generally the amount of amino acid is between 0.01 equivalent and 1.2 equivalent relative to the amount of compound of formula (II), preferably between 0.05 equivalent and 1.0 equivalent, preferentially between 0.1 equivalent and 0.75 equivalent. Generally the amount of malonic acid used is between 1 equivalent and 5 equivalents relative to the compound of formula (II), preferably between 1 equivalent and 2 equivalents, very preferentially between 1 equivalent and 1.5 equivalents, for example 1.2 equivalents.
[0059] Generally, acetic acid is used as a solvent. The amount of acetic acid used in the context of the present invention may be adjusted by those skilled in the art; in particular, the amount of acetic acid will be chosen so as to avoid precipitation of the diacid intermediate.
[0060] The use of acetic acid in the context of the present invention has the advantage in particular of stabilizing malonic acid as well as the compound of formula (I) obtained, in particular by avoiding the decarboxylation reaction of malonic acid into acetic acid, or of the compound of formula (I), for example into the compound of formula (IV).
[0061] J-norm; IV i
[0062] Advantageously, the use of acetic acid as a solvent in the process of the present invention allows continuous removal of the water produced during the condensation step of the process. Purification of the compound of formula (I) obtained is thus facilitated. By way of illustration, the ferulic acid formed according to the process of the present invention can be crystallized. The process can be operated with continuous removal of the water.
[0063] In the context of the present invention, the method may be carried out in the presence of a co-solvent. The choice of co-solvent is not particularly limited. The co-solvent may be polar, apolar, protic or aprotic. By way of illustration, the co-solvent may be chosen from ethers, alcohols, ketones, aromatic solvents. In general, the co-solvent is preferably selected from the group consisting of benzene, toluene, DMSO, DMF, dichloromethane, tetrahydrofuran, 2-methyl tetrahydrofuran, water, acetone, acetonitrile, 1,4-dioxane or an alcohol of formula R' -OH, or mixtures thereof, where R' represents a linear or branched alkyl chain comprising from 1 to 6 carbon atoms, preferably the alcohol is selected from methanol, ethanol, isopropanol, n-propanol, n-butanol, tert-butanol, 2,2-dimethylpropanol, hexane, pentane and cyclohexane.
[0064] Generally the compound of formula (II), the amino acid and the malonic acid are dissolved in acetic acid. In another aspect the compound of formula (II) and the amino acid are dissolved in acetic acid. The malonic acid may then be added directly or in solution in the acetic acid. The malonic acid in solution in the acetic acid may be added all at once, or over an extended period.
[0065] According to a particular aspect, the process for preparing a compound of formula (I) is carried out in the presence of at least one amino acid and a second catalyst preferably chosen from tertiary amines or pyridine derivative, preferably chosen from pyridine, niacin and nicotinamide.
[0066] In the context of the present invention, the quantity of second catalyst is between 0.05 equivalent and 1.2 equivalent relative to the quantity of compound of formula (II), preferably between 0.1 equivalent and 1.0 equivalent, preferentially between 0.2 equivalent and 0.75 equivalent.
[0067] According to a particular aspect, the second catalyst can be introduced in a catalytic amount. Generally, the amount of second catalyst is between 0.05 equivalent and 0.9 equivalent relative to the amount of compound formula (II), preferably between 0.1 equivalent and 0.8 equivalent, preferably between 0.2 equivalent and 0.75 equivalent. According to a particular aspect, the amino acid and the second catalyst are introduced in catalytic amounts.
[0068] Without wishing to be bound by any theory, the inventors have discovered that the joint use of an amino acid and a second catalyst makes it possible to improve the performance of the reaction for converting the compound of formula (II) into the compound of formula (I). The amino acid is in fact suitable for catalyzing the entire process. The second catalyst mainly improves the performance of the decarboxylation step.
[0069] The process advantageously improves the conversion of the compound of formula (II) into the compound of formula (I). The diacid intermediate compound obtained at the end of the condensation step is efficiently decarboxylated to obtain the compound of formula (I). Overall, the reaction for forming the compound of formula (I) being more efficient, the purification of the compound of formula (I) is facilitated.
[0070] The process can be operated with continuous water withdrawal.
[0071] Generally, the compound of formula (II), the amino acid, the second catalyst and the malonic acid are dissolved in acetic acid. According to another aspect, the compound of formula (II), the amino acid and the second catalyst are dissolved in acetic acid. The malonic acid can then be added directly or in solution in the acetic acid. The compound of formula (I) obtained at the end of the process according to the present invention can be purified by any method known to those skilled in the art, in particular by distillation, purification on chromatography, or crystallization.
[0072] Another aspect of the present invention relates to a process for the preparation of para-hydroxycinnamic acid of formula (I) oimuL (I) in which RI and R2 are, identical or different, independently, selected from the group consisting of hydrogen, C1-C6 alkyl groups, linear or branched, optionally substituted, C1-C6 alkenyl groups, linear or branched, optionally substituted, -CO2R, -OR, in which R is selected from hydrogen, C1-C6 alkyl groups, linear or branched, optionally substituted, C1-C6 alkenyl groups, linear or branched, optionally substituted, in which a para-hydroxybenzaldehyde of formula (II) in which RI and R2 are as described above
[0073] Formula: II! is reacted with malonic acid in the presence of at least one amino acid and a second catalyst characterized in that the amino acid and the second catalyst are introduced in catalytic amounts.
[0074] The process of the present invention is generally carried out in a solvent, preferably chosen from the group consisting of DMSO, acetic acid, toluene.
[0075] The process of the present invention can be operated continuously or in batch.
[0076] Generally, the process of the present invention is carried out under an inert atmosphere, for example under nitrogen, argon or under oxygen-depleted air.
[0077] The process of the present invention is generally carried out with stirring.
[0078] The process of the present invention is generally carried out at a temperature at which the solvent or solvent mixture is refluxing, for example at a temperature between 50°C and 110°C.
[0079] The process of the present invention is generally operated under reduced pressure or atmospheric pressure.
[0080] The duration of the process is generally between 2 hours and 24 hours, preferably between 4 hours and 12 hours.
[0081] The process for preparing a compound of formula (I) is carried out in the presence of at least one amino acid in catalytic quantity and a second catalyst, in catalytic quantity, preferably chosen from tertiary amines, niacin and nicotinamide, preferably chosen from pyridine, niacin and nicotinamide. In the context of this embodiment, the amino acid is introduced in catalytic quantity. Generally the amount of amino acid is between 0.01 equivalent and 1.2 equivalent relative to the amount of compound of formula (II), preferably between 0.05 equivalent and 1.0 equivalent, preferentially between 0.1 equivalent and 0.75 equivalent.
[0082] In the context of this embodiment, the second catalyst is introduced in a catalytic quantity. Generally, the quantity of second catalyst is between 0.05 equivalent and 0.9 equivalent relative to the quantity of compound formula (II), preferably between 0.1 equivalent and 0.8 equivalent, preferably between 0.2 equivalent and 0.75 equivalent.
[0083] The process can be operated with continuous water withdrawal.
[0084] Generally the compound of formula (II), the amino acid, the second catalyst and the malonic acid are dissolved in a solvent. In another aspect the compound of formula (II), the amino acid and the second catalyst are dissolved in a solvent. The malonic acid may then be added directly or dissolved in a solvent.
[0085] The compound of formula (I) obtained at the end of the process according to the present invention can be purified by any method known to those skilled in the art, in particular by distillation, purification by chromatography, or crystallization.
[0086] Finally, the present invention refers to the use of a compound of formula (I) as a synthesis intermediate, preferably for the synthesis of flavors. According to a particular aspect, the present invention refers to the use of a compound of formula (I) in which RI is hydrogen, R2 is chosen from a methoxy or ethoxy group for the synthesis of vanillin or ethylvanillin.
[0087] Examples
[0088] Example 1:
[0089] Vanillin (6.57 mmol), malonic acid (2 equivalents), and a catalyst, optionally a second catalyst, are mixed in a solvent (6.5 mL) according to Table 1. The reaction mixture is stirred under an inert atmosphere at 80°C for 6 hours. Table 1
[0090] The proportions of vanillin, diacid intermediate and ferulic acid are measured by NMR. The yield of ferulic acid is measured by HPLC.
[0091] The results are grouped in Table 2:
[0092] Table 2
[0093] Example 2: Vanillin (6.57 mmol), malonic acid (2 eq.), and a catalyst, optionally a second catalyst, are mixed in a solvent (6.5 mL) according to Table 3. The reaction mixture is stirred under an inert atmosphere at 95°C for 4 h 30 min.
[0094] Table 3 The proportions of vanillin, diacid intermediate, compound of formula (IV) and ferulic acid are measured by NMR.
[0095] The results are grouped in Table 4: Table 4
[0096] * The amount of acetic acid is measured as a percentage relative to the amount of VA+Diacid Intermediate+Ferulic Acid
[0097] Example 2.1 shows that the transformation of vanillin into ferulic acid in DMSO in the presence of glycine is possible. However, under these operating conditions, a greater formation of compound of formula (IV) resulting from the decarboxylation of ferulic acid is observed. The formation of acetic acid resulting from the decarboxylation of malonic acid is also observed. Thus, a significant excess of malonic acid and control of the reaction time and / or temperature is necessary to avoid the formation of compound of formula (IV).
[0098] Example 3:
[0099] Vanillin (400 mmol), acetic acid (100 mL), glycine (0.1 equivalent) and niacin (0.5 equivalent) are introduced into a flask equipped with a Vigreux column and a condenser. The mixture is refluxed at 80-82°C under reduced pressure.
[0100] A solution of malonic acid (1.2 equivalents) in acetic acid (300 mL) is added over a period of 2 hours. Solvent is distilled continuously. Distillation is maintained for a period of 2 hours.
[0101] After cooling, water is added, and ferulic acid is crystallized. The solid is filtered and washed with water. Ferulic acid is analyzed by NMR and gas chromatography. Ferulic acid is obtained with a non-optimized yield of 69% and a purity greater than 97%.
[0102] Example 4:
[0103] Bio-sourced vanillin (8 carbon atoms of bio-sourced origin, average isotopic deviation 13 C = -24%o) is reacted under the conditions of Example 3.
[0104] Ferulic acid with 8 carbon atoms of bio-sourced origin is obtained.
Claims
DEMANDS 1. Process for preparing para-hydroxycinnamic acid of formula (I) formula (I) in which RI and R2 are, identical or different, independently chosen from the group consisting of hydrogen, linear or branched C1-C6 alkyl groups, optionally substituted, linear or branched C1-C6 alkenyl groups, optionally substituted, -CO2R, -OR, in which R is chosen from hydrogen, linear or branched C1-C6 alkyl groups, optionally substituted, linear or branched C1-C6 alkenyl groups, optionally substituted, in which a para-hydroxybenzaldehyde of formula (II) in which RI and R2 are such as described above is reacted with malonic acid in the presence of at least one amino acid and acetic acid.
2. A preparation method according to claim 1 in which acetic acid is used as a solvent.
3. A preparation method according to any one of claims 1 or 2 wherein the quantity of amino acid is between 0.05 equivalent and 5 equivalent.
4. A preparation method according to any one of claims 1 to 3 wherein the amount of amino acid is between 0.01 equivalent and 1.2 equivalent relative to the amount of compound formula (II), preferably between 0.05 equivalent and 1.0 equivalent, preferably between 0.1 equivalent and 0.75 equivalent.
5. A preparation method according to any one of claims 1 to 4, wherein para-hydroxybenzaldehyde of formula (II) and malonic acid are reacted in the presence of an amino acid and a second catalyst.
6. A preparation method according to any one of claims 1 to 5, wherein the second catalyst is introduced in catalytic quantity.
7. A preparation method according to any one of claims 4 to 6, wherein the second catalyst is selected from tertiary amines, niacin or nicotinamide, preferably selected from pyridine, niacin or nicotinamide.
8. A method according to any one of the preceding claims wherein the amino acid is selected from proline, glycine, histidine.
9. A method according to any one of the preceding claims wherein RI is a hydrogen and R2 is a methoxy or ethoxy group.
10. A process according to any one of the preceding claims, wherein the process is carried out at a temperature between 50°C and 110°C.
11. A process according to any one of the preceding claims, wherein the process is carried out in the presence of a co-solvent.
